🚀 Gate Square “Gate Fun Token Challenge” is Live!
Create tokens, engage, and earn — including trading fee rebates, graduation bonuses, and a $1,000 prize pool!
Join Now 👉 https://www.gate.com/campaigns/3145
💡 How to Participate:
1️⃣ Create Tokens: One-click token launch in [Square - Post]. Promote, grow your community, and earn rewards.
2️⃣ Engage: Post, like, comment, and share in token community to earn!
📦 Rewards Overview:
Creator Graduation Bonus: 50 GT
Trading Fee Rebate: The more trades, the more you earn
Token Creator Pool: Up to $50 USDT per user + $5 USDT for the first 50 launche
Biopharma aims for $100 million for a cryptocurrency fund to support cancer treatment.
Australian biotechnology company Propanc Biopharma has raised up to 100 million USD from Hexstone Capital, a family office specializing in cryptocurrency, to build a digital asset treasury and advance the PRP cancer therapy into human trials by 2026.
The agreement includes an initial investment of 1 million USD and a maximum of 99 million USD thereafter within 12 months. CEO James Nathanielsz stated that establishing a cryptocurrency treasury will help strengthen finances and support the company's “transformative” growth phase.
Propanc has not disclosed what type of digital asset it will purchase, but Hexstone has previously invested in Bitcoin, Ether, Solana, and Injective.
This move follows the trend of biotechnology companies like Sonnet BioTherapeutics shifting to cryptocurrency, yet Propanc's PPCB stock still fell 10.5% on Nasdaq and lost 46.7% over the past month.